Abstract:Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict, and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale membrane bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30-100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter, Cupriavidus, Pseudomonas and Leucobacter. By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. KEY POINTS: • Multiple pharmaceuticals were removed by stable microbial communities. • Microbial key players of five main pharmaceuticals were identified.

Marine bacteria-mediated abiotic-biotic coupling degradation mechanism of ibuprofen

Ibuprofen degradation by mixed bacterial consortia: Metabolic pathway and microbial community analysis

Ibuprofen degradation using a Co-doped carbon matrix derived from peat as a peroxymonosulphate activator

Integrated Toxicology, Metabolomics, and Transcriptomics Analyses Reveal the Biodegradation and Adaptation Mechanisms to Bde-47 in Pseudomonas Plecoglossicida

Removal of antibiotic resistant bacteria and genes by post-pyrolysis bio-hybridcarbon/peroxymonosulfate system: Gene-degrading intermediates of bioinformatic identification based on corrected-nanopore sequencing and preference mechanism

High-throughput Pyrosequencing Analysis of Bacteria Relevant to Cometabolic and Metabolic Degradation of Ibuprofen in Horizontal Subsurface Flow Constructed Wetlands.

Biotransformation pathways of pharmaceuticals and personal care products (PPCPs) during acidogenesis and methanogenesis of anaerobic digestion

Aerobic degradation of ketoprofen by marine consortia: Fenton-like reaction and degradation pathway

Degradation of Ibuprofen by the Electro/Fe3+/Peroxydisulfate Process: Reactive Kinetics, Degradation Products and Mechanism

Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors

High-efficient degradation of ibuprofen as typical PPCP through a novel electrochemical approach of traditional peroxone method

Elucidating polyethylene microplastic degradation mechanisms and metabolic pathways via iron-enhanced microbiota dynamics in marine sediments

Microbial degradation mechanisms of surface petroleum contaminated seawater in a typical oil trading port

Biodegradation of Microtoxic Phenylpropanoids (Phenylpropanoic Acid and Ibuprofen) by Bacteria and the Relevance for Their Removal from Wastewater Treatment Plants

New Insights into the Degradation Mechanism of Ibuprofen in UV/H2O2 Process: Role of Natural Dissolved Matter in Hydrogen Transfer Reactions

Enhanced antibiotic wastewater degradation by intimately coupled B-Bi3O4Cl photocatalysis and biodegradation reactor: Elucidating degradation principle systematically

Understanding the role of bacterial cellular adsorption, accumulation and bioavailability regulation by biosurfactant in affecting biodegradation efficacy of polybrominated diphenyl ethers

Removal of Pharmaceuticals and Personal Care Products by Ammonia Oxidizing Bacteria Acclimated in a Membrane Bioreactor: Contributions of Cometabolism and Endogenous Respiration.

Biodegradation of organic micropollutants by anoxic denitrification: Roles of extracellular polymeric substance adsorption, enzyme catalysis, and reactive oxygen species oxidation

Microbial Metabolic Enzymes, Pathways and Microbial Hosts for Co-Metabolic Degradation of Organic Micropollutants in Wastewater

Biodegradation of phthalic acid esters by a novel marine bacterial strain RL-BY03: Characterization, metabolic pathway, bioaugmentation and genome analysis